{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:23:45Z","timestamp":1791685425470,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/cddis.2011.87","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T10:04:30Z","timestamp":1314871470000},"page":"e203-e203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor"],"prefix":"10.1038","volume":"2","author":[{"given":"D","family":"Chauvier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Renolleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Holifanjaniaina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ankri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bezault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Schwendimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Casimir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hoebeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Smirnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Debret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-P","family":"Trichet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"H\u00e9bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-M","family":"Rauzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Matecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lacampagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Rustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Gressens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Charriaut-Marlangue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Jacotot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,1]]},"reference":[{"key":"BFcddis201187_CR1","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.ijgo.2009.07.016","volume":"107","author":"JE Lawn","year":"2009","unstructured":"Lawn JE, Lee AC, Kinney M, Sibley L, Carlo WA, Paul VK et al. Two million intrapartum-related stillbirths and neonatal deaths: where, why, and what can be done? Int J Gynaecol Obstet 2009; 107: S5.","journal-title":"Int J Gynaecol Obstet"},{"key":"BFcddis201187_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00019052-200204000-00005","volume":"15","author":"AJ du Plessis","year":"2002","unstructured":"du Plessis AJ, Volpe JJ . Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol 2002; 15: 151\u2013157.","journal-title":"Curr Opin Neurol"},{"key":"BFcddis201187_CR3","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1056\/NEJMra041996","volume":"351","author":"DM Ferriero","year":"2004","unstructured":"Ferriero DM . Neonatal brain injury. N Engl J Med 2004; 351: 1985\u20131995.","journal-title":"N Engl J Med"},{"key":"BFcddis201187_CR4","doi-asserted-by":"publisher","first-page":"e1000389","DOI":"10.1371\/journal.pmed.1000389","volume":"8","author":"JE Lawn","year":"2011","unstructured":"Lawn JE, Bahl R, Bergstrom S, Bhutta ZA, Darmstadt GL, Ellis M et al. Setting research priorities to reduce almost one million deaths from birth asphyxia by 2015. PLoS Med 2011; 8: e1000389.","journal-title":"PLoS Med"},{"key":"BFcddis201187_CR5","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJMoa0900854","volume":"361","author":"DV Azzopardi","year":"2009","unstructured":"Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009; 361: 1349\u20131358.","journal-title":"N Engl J Med"},{"key":"BFcddis201187_CR6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.clp.2009.07.013","volume":"36","author":"FF Gonzalez","year":"2009","unstructured":"Gonzalez FF, Ferriero DM . Neuroprotection in the newborn infant. Clin Perinatol 2009; 36: 859\u2013880.","journal-title":"Clin Perinatol"},{"key":"BFcddis201187_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.neuroscience.2007.06.060","volume":"149","author":"FJ Northington","year":"2007","unstructured":"Northington FJ, Zelaya ME, O\u2019Riordan DP, Blomgren K, Flock DL, Hagberg H et al. Failure to complete apoptosis following neonatal hypoxia-ischemia manifests as \u2018continuum\u2019 phenotype of cell death and occurs with multiple manifestations of mitochondrial dysfunction in rodent forebrain. Neuroscience 2007; 149: 822\u2013833.","journal-title":"Neuroscience"},{"key":"BFcddis201187_CR8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1177\/0883073809337920","volume":"24","author":"AM Kaindl","year":"2009","unstructured":"Kaindl AM, Favrais G, Gressens P . Molecular mechanisms involved in injury to the preterm brain. J Child Neurol 2009; 24: 1112\u20131118.","journal-title":"J Child Neurol"},{"key":"BFcddis201187_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/00004647-200204000-00006","volume":"22","author":"R Gill","year":"2002","unstructured":"Gill R, Soriano M, Blomgren K, Hagberg H, Wybrecht R, Miss MT et al. Role of caspase-3 activation in cerebral ischemia-induced neurodegeneration in adult and neonatal brain. J Cereb Blood Flow Metab 2002; 22: 420\u2013430.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFcddis201187_CR10","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1471-4159.2006.04269.x","volume":"100","author":"S Renolleau","year":"2007","unstructured":"Renolleau S, Fau S, Goyenvalle C, Joly LM, Chauvier D, Jacotot E et al. Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender. J Neurochem 2007; 100: 1062\u20131071.","journal-title":"J Neurochem"},{"key":"BFcddis201187_CR11","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1523\/JNEUROSCI.5832-08.2009","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang X, Carlsson Y, Basso E, Zhu C, Rousset CI, Rasola A et al. Developmental shift of cyclophilin D contribution to hypoxic\u2013ischemic brain injury. J Neurosci 2009; 29: 2588\u20132596.","journal-title":"J Neurosci"},{"key":"BFcddis201187_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1203\/00006450-199711000-00022","volume":"42","author":"AD Edwards","year":"1997","unstructured":"Edwards AD, Yue X, Cox P, Hope PL, Azzopardi DV, Squier MV et al. Apoptosis in the brains of infants suffering intrauterine cerebral injury. Pediatr Res 1997; 42: 684\u2013689.","journal-title":"Pediatr Res"},{"key":"BFcddis201187_CR13","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1177\/0883073809338212","volume":"24","author":"H Hagberg","year":"2009","unstructured":"Hagberg H, Mallard C, Rousset CI, Wang X . Apoptotic mechanisms in the immature brain: involvement of mitochondria. J Child Neurol 2009; 24: 1141\u20131146.","journal-title":"J Child Neurol"},{"key":"BFcddis201187_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/sj.cdd.4401545","volume":"12","author":"C Zhu","year":"2005","unstructured":"Zhu C, Wang X, Xu F, Bahr BA, Shibata M, Uchiyama Y et al. The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia\u2013ischemia. Cell Death Differ 2005; 12: 162\u2013176.","journal-title":"Cell Death Differ"},{"key":"BFcddis201187_CR15","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1161\/STROKEAHA.110.589051","volume":"41","author":"X Wang","year":"2010","unstructured":"Wang X, Han W, Du X, Zhu C, Carlsson Y, Mallard C et al. Neuroprotective effect of Bax-inhibiting peptide on neonatal brain injury. Stroke 2010; 41: 2050\u20132055.","journal-title":"Stroke"},{"key":"BFcddis201187_CR16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.cdd.4402053","volume":"14","author":"C Zhu","year":"2007","unstructured":"Zhu C, Wang X, Huang Z, Qiu L, Xu F, Vahsen N et al. Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia\u2013ischemia. Cell Death Differ 2007; 14: 775\u2013784.","journal-title":"Cell Death Differ"},{"key":"BFcddis201187_CR17","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1126\/science.281.5381.1312","volume":"281","author":"NA Thornberry","year":"1998","unstructured":"Thornberry NA, Lazebnik Y . Caspases: enemies within. Science 1998; 281: 1312\u20131316.","journal-title":"Science"},{"key":"BFcddis201187_CR18","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1021\/jm000060f","volume":"43","author":"RV Talanian","year":"2000","unstructured":"Talanian RV, Brady KD, Cryns VL . Caspases as targets for anti-inflammatory and anti-apoptotic drug discovery. J Med Chem 2000; 43: 3351\u20133371.","journal-title":"J Med Chem"},{"key":"BFcddis201187_CR19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/35037739","volume":"407","author":"J Yuan","year":"2000","unstructured":"Yuan J, Yankner BA . Apoptosis in the nervous system. Nature 2000; 407: 802\u2013809.","journal-title":"Nature"},{"key":"BFcddis201187_CR20","doi-asserted-by":"publisher","first-page":"9677","DOI":"10.1074\/jbc.272.15.9677","volume":"272","author":"RV Talanian","year":"1997","unstructured":"Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D et al. Substrate specificities of caspase family proteases. J Biol Chem 1997; 272: 9677\u20139682.","journal-title":"J Biol Chem"},{"key":"BFcddis201187_CR21","doi-asserted-by":"publisher","first-page":"32608","DOI":"10.1074\/jbc.273.49.32608","volume":"273","author":"M Garcia-Calvo","year":"1998","unstructured":"Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA et al. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 1998; 273: 32608\u201332613.","journal-title":"J Biol Chem"},{"key":"BFcddis201187_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/sj.cdd.4400497","volume":"6","author":"M Garcia-Calvo","year":"1999","unstructured":"Garcia-Calvo M, Peterson EP, Rasper DM, Vaillancourt JP, Zamboni R, Nicholson DW et al. Purification and catalytic properties of human caspase family members. Cell Death Differ 1999; 6: 362\u2013369.","journal-title":"Cell Death Differ"},{"key":"BFcddis201187_CR23","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1172\/JCI2169","volume":"101","author":"Y Cheng","year":"1998","unstructured":"Cheng Y, Deshmukh M, D\u2019Costa A, Demaro JA, Gidday JM, Shah A et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic\u2013ischemic brain injury. J Clin Invest 1998; 101: 1992\u20131999.","journal-title":"J Clin Invest"},{"key":"BFcddis201187_CR24","doi-asserted-by":"publisher","first-page":"30128","DOI":"10.1074\/jbc.M202931200","volume":"277","author":"BH Han","year":"2002","unstructured":"Han BH, Xu D, Choi J, Han Y, Xanthoudakis S, Roy S et al. Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic\u2013ischemic brain injury. J Biol Chem 2002; 277: 30128\u201330136.","journal-title":"J Biol Chem"},{"key":"BFcddis201187_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/01.WCB.0000100061.36077.5F","volume":"24","author":"LM Joly","year":"2004","unstructured":"Joly LM, Mucignat V, Mariani J, Plotkine M, Charriaut-Marlangue C . Caspase inhibition after neonatal ischemia in the rat brain. J Cereb Blood Flow Metab 2004; 24: 124\u2013131.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFcddis201187_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/ana.21714","volume":"66","author":"J Puyal","year":"2009","unstructured":"Puyal J, Vaslin A, Mottier V, Clarke PG . Postischemic treatment of neonatal cerebral ischemia should target autophagy. Ann Neurol 2009; 66: 378\u2013389.","journal-title":"Ann Neurol"},{"key":"BFcddis201187_CR27","doi-asserted-by":"publisher","first-page":"13761","DOI":"10.1523\/JNEUROSCI.4246-09.2009","volume":"29","author":"H Karatas","year":"2009","unstructured":"Karatas H, Aktas Y, Gursoy-Ozdemir Y, Bodur E, Yemisci M, Caban S et al. A nanomedicine transports a peptide caspase-3 inhibitor across the blood\u2013brain barrier and provide1neuroprotection. J Neurosci 2009; 29: 13761\u201313769.","journal-title":"J Neurosci"},{"key":"BFcddis201187_CR28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/384368a0","volume":"384","author":"K Kuida","year":"1996","unstructured":"Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384: 368\u2013372.","journal-title":"Nature"},{"key":"BFcddis201187_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0092-8674(00)81476-2","volume":"94","author":"K Kuida","year":"1998","unstructured":"Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998; 94: 325\u2013337.","journal-title":"Cell"},{"key":"BFcddis201187_CR30","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1101\/gad.12.9.1304","volume":"12","author":"L Bergeron","year":"1998","unstructured":"Bergeron L, Perez GI, Macdonald G, Shi L, Sun Y, Jurisicova A et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 1998; 12: 1304\u20131314.","journal-title":"Genes Dev"},{"key":"BFcddis201187_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.nbd.2005.12.017","volume":"22","author":"T West","year":"2006","unstructured":"West T, Atzeva M, Holtzman DM . Caspase-3 deficiency during development increases vulnerability to hypoxic\u2013ischemic injury through caspase-3-independent pathways. Neurobiol Dis 2006; 22: 523\u2013537.","journal-title":"Neurobiol Dis"},{"issue":"5","key":"BFcddis201187_CR32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/ana.22431","volume":"70","author":"Ylva Carlsson","year":"2011","unstructured":"Carlsson Y, Schwendimann L, Vontell R, Rousset CI, Wang X, Lebon S et al. Genetic inhibition of caspase-2 reduces hypoxic\u2013ischemic and excitotoxic neonatal brain injury. Ann Neurol 2011; e-pub ahead of print 28 March 2011; doi:10.1002\/ana.22431.","journal-title":"Annals of Neurology"},{"key":"BFcddis201187_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.cdd.4402044","volume":"14","author":"D Chauvier","year":"2007","unstructured":"Chauvier D, Ankri S, Charriaut-Marlangue C, Casimir R, Jacotot E . Broad-spectrum caspase inhibitors: from myth to reality? Cell Death Differ 2007; 14: 387\u2013391.","journal-title":"Cell Death Differ"},{"key":"BFcddis201187_CR34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1046\/j.1471-4159.2003.01832.x","volume":"86","author":"C Zhu","year":"2003","unstructured":"Zhu C, Qiu L, Wang X, Hallin U, Cand\u00e9 C, Kroemer G et al. Involvement of apoptosis-inducing factor in neuronal death after hypoxia\u2013ischemia in the neonatal rat brain. J Neurochem 2003; 86: 306\u2013317.","journal-title":"J Neurochem"},{"key":"BFcddis201187_CR35","doi-asserted-by":"publisher","first-page":"6779","DOI":"10.1021\/jm050307e","volume":"48","author":"SD Linton","year":"2005","unstructured":"Linton SD, Aja T, Armstrong RA, Bai X, Chen LS, Chen N et al. First-in-class pan caspase inhibitor developed for the treatment of liver disease. J Med Chem 2005; 48: 6779\u20136782.","journal-title":"J Med Chem"},{"key":"BFcddis201187_CR36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2174\/092986706776055733","volume":"13","author":"R Leung-Toung","year":"2006","unstructured":"Leung-Toung R, Zhao Y, Li W, Tam TF, Karimian K, Spino M et al. Thiol proteases: inhibitors and potential therapeutic targets. Curr Med Chem 2006; 13: 547\u2013581.","journal-title":"Curr Med Chem"},{"key":"BFcddis201187_CR37","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/sj.cdd.4402260","volume":"15","author":"GP McStay","year":"2008","unstructured":"McStay GP, Salvesen GS, Green DR . Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ 2008; 15: 322\u2013331.","journal-title":"Cell Death Differ"},{"key":"BFcddis201187_CR38","doi-asserted-by":"publisher","first-page":"42441","DOI":"10.1074\/jbc.M304895200","volume":"278","author":"A Schweizer","year":"2003","unstructured":"Schweizer A, Briand C, Grutter MG . Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway. J Biol Chem 2003; 278: 42441\u201342447.","journal-title":"J Biol Chem"},{"key":"BFcddis201187_CR39","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s10495-005-1681-x","volume":"10","author":"D Chauvier","year":"2005","unstructured":"Chauvier D, Lecoeur H, Langonn\u00e9 A, Borgne-Sanchez A, Mariani J, Martinou JC et al. Upstream control of apoptosis by caspase-2 in serum-deprived primary neurons. Apoptosis 2005; 10: 1243\u20131259.","journal-title":"Apoptosis"},{"key":"BFcddis201187_CR40","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ana.21516","volume":"64","author":"M Dzietko","year":"2008","unstructured":"Dzietko M, Boos V, Sifringer M, Polley O, Gerstner B, Genz K et al. A critical role for Fas\/CD-95 dependent signaling pathways in the pathogenesis of hyperoxia-induced brain injury. Ann Neurol 2008; 64: 664\u2013673.","journal-title":"Ann Neurol"},{"key":"BFcddis201187_CR41","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1161\/01.STR.29.7.1454","volume":"29","author":"S Renolleau","year":"1998","unstructured":"Renolleau S, Aggoun-Zouaoui D, Ben-Ari Y, Charriaut-Marlangue C . A model of transient unilateral focal ischemia with reperfusion in the P7 neonatal rat: morphological changes indicative of apoptosis. Stroke 1998; 29: 1454\u20131461.","journal-title":"Stroke"},{"key":"BFcddis201187_CR42","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.2353\/ajpath.2009.090257","volume":"175","author":"S Villapol","year":"2009","unstructured":"Villapol S, Bonnin P, Fau S, Baud O, Renolleau S, Charriault-Marlangue C . Unilateral blood flow decrease induces bilateral and symmetric responses in the immature brain. Am J Pathol 2009; 175: 2111\u20132120.","journal-title":"Am J Pathol"},{"key":"BFcddis201187_CR43","doi-asserted-by":"publisher","first-page":"13430","DOI":"10.1074\/jbc.M108029200","volume":"277","author":"Y Guo","year":"2002","unstructured":"Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES . Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 2002; 277: 13430\u201313437.","journal-title":"J Biol Chem"},{"key":"BFcddis201187_CR44","doi-asserted-by":"publisher","first-page":"29803","DOI":"10.1074\/jbc.M204185200","volume":"277","author":"JD Robertson","year":"2002","unstructured":"Robertson JD, Enoksson M, Suomela M, Zhivotovsky B, Orrenius S . Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 2002; 277: 29803\u201329809.","journal-title":"J Biol Chem"},{"key":"BFcddis201187_CR45","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0165-0270(90)90131-X","volume":"35","author":"P Andin\u00e9","year":"1990","unstructured":"Andin\u00e9 P, Thordstein M, Kjellmer I, Nordborg C, Thiringer K, Wennberg E et al. Evaluation of brain damage in a rat model of neonatal hypoxic\u2013ischemia. J Neurosci Methods 1990; 35: 253\u2013260.","journal-title":"J Neurosci Methods"},{"key":"BFcddis201187_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0165-6147(00)88999-3","volume":"16","author":"AJ Hunter","year":"1995","unstructured":"Hunter AJ, Green AR, Cross AJ . Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs? Trends Pharmacol Sci 1995; 16: 123\u2013128.","journal-title":"Trends Pharmacol Sci"},{"key":"BFcddis201187_CR47","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nature09788","volume":"472","author":"MA Burguillos","year":"2011","unstructured":"Burguillos MA, Deierborg T, Kavanagh E, Persson A, Hajji N, Garcia-Quintanilla A et al. Caspase signalling controls microglia activation and neurotoxicity. Nature 2011; 472: 319\u2013324.","journal-title":"Nature"},{"key":"BFcddis201187_CR48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pharmthera.2008.07.003","volume":"120","author":"FF Gonzalez","year":"2008","unstructured":"Gonzalez FF, Ferriero DM . Therapeutics for neonatal brain injury. Pharmacol Ther 2008; 120: 43\u201353.","journal-title":"Pharmacol Ther"},{"key":"BFcddis201187_CR49","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1006\/meth.1999.0746","volume":"17","author":"JC Wu","year":"1999","unstructured":"Wu JC, Fritz LC . Irreversible caspase inhibitors: tools for studying apoptosis. Methods 1999; 17: 320\u2013328.","journal-title":"Methods"}],"container-title":["Cell Death & Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cddis201187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cddis201187","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis201187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:44:24Z","timestamp":1672962264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis201187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,1]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,9]]}},"alternative-id":["BFcddis201187"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2011.87","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,1]]},"assertion":[{"value":"20 July 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Some of the authors (DC, SA, MB, RC, MS, A-PT, EB, and EJ) were former employees of a biopharmaceutical company (Theraptosis SA, Paris, France) that closed down in late 2008. Other authors (SR, SH, LS, CR, JH, GD, YC, XW, MH, J-MR, SM, AL, PR, JM, HH, PG, CC-M) declare no conflict of interest. First public disclosure of TRP601-related data occurred in June 2008 (6th Hershey Conference, Ecquevilly, France). TRP601 rights were acquired in 2009 by Chiesi Pharmaceutici SpA, Parma, Italy (; Annual Report 2009, p 50).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}